AMYLYX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.82 USD | +3.70% |
|
-8.54% | -87.64% |
| 09/05 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 09/05 | Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Biopharmaceuticals | +3.70% | -8.54% | -87.64% | -93.42% | - | 119M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AMLX Stock
- Charts Amylyx Pharmaceuticals, Inc.
- Comparison Chart
